The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, in Primary Sjogren's Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial St Clair, E., Baer, A. N., Noaiseh, G., Parke, A., Coca, A., Utset, T., Genovese, M. C., Wallace, D. J., McNamara, J., Boyle, K., Keyes-Elstein, L., Franchimont, N., James, J. A., Autoimmunity Ctr Excellence WILEY-BLACKWELL. 2015

View details for Web of Science ID 000370860204752